As shown in Table 4, the gallstone rate in the CRC patients (25.0%) and BRAF-positive MSS group (33.3%) was markedly higher than that in the healthy subjects (9.3%) (Fig. 4A–C). Here, BRAF is linked to colorectal carcinoma.